about
Interatomic potentials and solvation parameters from protein engineering data for buried residuesEukaryotic initiation factor (eIF) 1 carries two distinct eIF5-binding faces important for multifactor assembly and AUG selectionThree-dimensional structure of toxin OSK1 from Orthochirus scrobiculosus scorpion venomSmall-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4GSelective pharmacological targeting of a DEAD box RNA helicase.Use of hydrostatic pressure for modulation of protein chemical modification and enzymatic selectivity.The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.The C-terminal domain of eukaryotic initiation factor 5 promotes start codon recognition by its dynamic interplay with eIF1 and eIF2βA multifunctional catalyst that stereoselectively assembles prodrugs.Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach.Visualizing small differences using subtractive chromatographic analysis.Structure elucidation of uniformly 13C labeled small molecule natural products.The protecting-group free selective 3'-functionalization of nucleosidesInvestigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.Broadband inversion of 1J(CC) responses in 1,n-ADEQUATE spectra.Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.Using Electron Paramagnetic Resonance Spectroscopy To Facilitate Problem Solving in Pharmaceutical Research and Development.Oxyfunctionalization of the Remote C-H Bonds of Aliphatic Amines by Decatungstate Photocatalysis.Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists.A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes.NMR study of monomer-dimer equilibrium of barstar in solution.Structure elucidation of uniformly (13)C labeled small molecule natural products.Facile Quantum Yield Determination via NMR Actinometry.pKa measurements for the SAMPL6 prediction challenge for a set of kinase inhibitor-like fragmentsDiscovery of a Photoinduced Dark Catalytic Cycle Using in Situ LED-NMR SpectroscopypK measurements for the SAMPL6 prediction challenge for a set of kinase inhibitor-like fragmentsBand-Selective 2D HSQMBC: A Universal Technique for Detection and Measurement of 35,37Cl Isotope Effects for 13C NucleiComplex macrocycle exploration: parallel, heuristic, and constraint-based conformer generation using ForceGen.13C NMR-Based Approaches for Solving Challenging Stereochemical Problems.Identification of individual protein-ligand NOEs in the limit of intermediate exchange[I87E mutation prevents barstar dimerization]1J(CC)-edited HSQC-1,n-ADEQUATE: a new paradigm for simultaneous direct and long-range carbon-carbon correlationDiscovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesityConiothyrione: anatomy of a structure revisionPromotion of a Ti-Mediated Mannich Reaction by a Proton SourceSAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonistsAsymmetric synthesis of cyclic indole aminals via 1,3-stereoinductionSecondary amine selective Petasis (SASP) bioconjugationPBLG as a versatile liquid crystalline medium for anisotropic NMR data acquisitionBenzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety
P50
Q24644861-E62E29B3-9360-4E77-85CF-C0674BD4F1BCQ27648930-1320A4A7-7F28-4264-B9B2-BE63821A6D60Q27734966-88CD5E40-2999-43A1-9CC8-084CEE645B93Q28285121-1518C3BD-C81A-4888-9FF3-08D26096672AQ33319563-DDAA5C2A-19D5-4749-83E0-AA342C87584DQ33467714-7CF6BF9E-6735-4AEC-AC1B-80D7D2C1E4C4Q33630394-A0165562-D39E-4263-BC87-CFE8151F7E43Q36106749-17200737-EAC0-429B-A295-DB66AA6BB66AQ36357128-437D01D9-17AC-4B13-AA32-AE20A83D7797Q38966078-4E8CBFFA-4A69-4A00-85C6-FD9D692EEA73Q39356082-9D78ED37-8B1E-4179-A716-CEDB0DA3CA15Q40869381-67B882E0-0869-49DC-9CA4-BF4E38556894Q41952812-789A639D-9E34-4530-8355-2CAAAE5B57EFQ42732674-1E159F38-1C62-41EC-9F5D-298CC9C3994EQ46045629-332D5266-3DDB-42C2-A7FE-656DDCC2000EQ46442070-3599F7C1-214F-4E07-8F77-5056E2315218Q46530076-3BA046AC-967B-4C9F-A004-9680E60B0836Q48168409-134503BF-161E-48C2-AF2C-FEDD3A9FEF30Q48308326-C6889780-66D8-404F-BCB7-F7F1BF50052EQ48600067-231DC601-03A5-4DB9-BF28-3A8333B58366Q49308332-ABAF7C3C-CAC2-430D-8640-3FD1CC0B2983Q50734565-4A5D0C7A-469E-45B9-9799-FA6E8A69D34CQ52625812-22165E8D-AF19-411B-9B9C-0098488AECF8Q57549142-85D67E2C-2C2E-4029-A5F9-7BB1B2DA3D33Q57792005-8B4868E0-F7CD-4557-A4B1-BD7341182C82Q58597404-9D14EB23-3018-490F-B8CB-004E6C8903D7Q63349821-EB2D1FE4-5B5B-4F58-960B-F77AA753E3B5Q64900233-1843D6EC-5373-4292-9F8E-D1F5C9C8C2EAQ64943096-4E4783BD-5638-4048-873C-B98F453A3F13Q80238794-52372E33-6072-4C33-9C46-0E9919D780EFQ81113949-A0F4D623-C8FA-48A2-9709-3BCB25ACE8A5Q85007455-0810BDDB-BF84-4327-B3A9-22FF1ED2DF48Q85174102-CF211AE2-78F9-4FDB-9910-FFCD954C0965Q86793792-11B73D84-7A8E-4B59-B3E9-99AC763C66ECQ86889107-0FB4BE50-F6B8-4AA5-83A6-73E6372C7C20Q87334336-A2E2BC57-96E8-439C-969D-EFFD6415A065Q87672198-C1CB42EA-C2A0-4A31-AA89-19598F3BDF4FQ89941027-C8D5EA88-EAB4-4AD9-90AA-8D8C9472646CQ92498098-BC8F9126-92BC-4071-A36E-55FD5B0C8BA9Q92705103-60518325-FD9B-43D5-8FFC-C28C4409921F
P50
description
researcher ORCID ID = 0000-0002-6589-707X
@en
wetenschapper
@nl
name
Mikhail Reibarkh
@ast
Mikhail Reibarkh
@en
Mikhail Reibarkh
@es
Mikhail Reibarkh
@nl
type
label
Mikhail Reibarkh
@ast
Mikhail Reibarkh
@en
Mikhail Reibarkh
@es
Mikhail Reibarkh
@nl
prefLabel
Mikhail Reibarkh
@ast
Mikhail Reibarkh
@en
Mikhail Reibarkh
@es
Mikhail Reibarkh
@nl
P106
P1153
6508317033
P31
P496
0000-0002-6589-707X